moventig
kyowa kirin holdings b.v. - naloxegol oxalate - constipation; opioid-related disorders - peripheral opioid receptor antagonists, drugs for constipation - treatment of opioid-induced constipation (oic) in adult patients who have had an inadequate response to laxative(s).
moventig 12.5mg tablets
kyowa kirin ltd - naloxegol oxalate - tablet - 12.5mg
moventig 25mg tablets
kyowa kirin ltd - naloxegol oxalate - tablet - 25mg
moventig 12.5 mg
abir therapeutics ltd, israel - naloxegol as oxalate - film coated tablets - naloxegol as oxalate 12.5 mg - naloxegol - moventig is indicated for the treatment of opioid-induced constipation (oic) in adult patients who have had an inadequate response to laxative(s).
moventig 12.5 mg
abir therapeutics ltd, israel - naloxegol as oxalate - film coated tablets - naloxegol as oxalate 12.5 mg - naloxegol - moventig is indicated for the treatment of opioid-induced constipation (oic) in adult patients who have had an inadequate response to laxative(s).
moventig 25 mg
abir therapeutics ltd, israel - naloxegol as oxalate - film coated tablets - naloxegol as oxalate 25 mg - naloxegol - moventig is indicated for the treatment of opioid-induced constipation (oic) in adult patients who have had an inadequate response to laxative(s).
moventig 25 mg
abir therapeutics ltd, israel - naloxegol as oxalate - film coated tablets - naloxegol as oxalate 25 mg - naloxegol - moventig is indicated for the treatment of opioid-induced constipation (oic) in adult patients who have had an inadequate response to laxative(s).
movantik tablet
knight therapeutics inc. - naloxegol (naloxegol oxalate) - tablet - 12.5mg - naloxegol (naloxegol oxalate) 12.5mg - miscellaneous gi drugs
movantik tablet
knight therapeutics inc. - naloxegol (naloxegol oxalate) - tablet - 25mg - naloxegol (naloxegol oxalate) 25mg - miscellaneous gi drugs